Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $7.5 million.

  • BioCorRx's Liabilities and Shareholders Equity rose 107057.55% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 107047.44%. This contributed to the annual value of $385941.0 for FY2024, which is 75.75% down from last year.
  • As of Q3 2025, BioCorRx's Liabilities and Shareholders Equity stood at $7.5 million, which was up 107057.55% from $6.7 million recorded in Q2 2025.
  • BioCorRx's Liabilities and Shareholders Equity's 5-year high stood at $7.5 million during Q3 2025, with a 5-year trough of $317444.0 in Q1 2024.
  • Over the past 5 years, BioCorRx's median Liabilities and Shareholders Equity value was $819249.0 (recorded in 2022), while the average stood at $1.9 million.
  • Per our database at Business Quant, BioCorRx's Liabilities and Shareholders Equity crashed by 5923.68% in 2022 and then surged by 204245.1% in 2025.
  • BioCorRx's Liabilities and Shareholders Equity (Quarter) stood at $819975.0 in 2021, then dropped by 6.51% to $766594.0 in 2022, then crashed by 49.27% to $388887.0 in 2023, then decreased by 0.76% to $385941.0 in 2024, then skyrocketed by 1851.98% to $7.5 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $7.5 million for Q3 2025, versus $6.7 million for Q2 2025 and $6.8 million for Q1 2025.